Skip to main content
. Author manuscript; available in PMC: 2015 Feb 1.
Published in final edited form as: JAMA Ophthalmol. 2014 Feb 1;132(2):214–222. doi: 10.1001/jamaophthalmol.2013.5636

Table 4.

Mobility improvement scores (in logits) for each crossover period, and across both periods

Real
Mean (SD)
Sham
Mean (SD)
Difference
Mean (SD)
T-test (2 tailed)
Period 1 a 1.9b (3.3)
n = 33
1.2b (2.2)
n = 28
0.7 (2.9)
95% CI −0.8 to 2.1
t(59) = 0.88, p = 0.38
Period 2 a 2.0b (3.4)
n = 28
1.4b (2.8)
n = 33
0.6 (3.1)
95% CI −2.1 to 1.1
t(59) = 0.69, p = 0.50
Periods 1 and 2 c
(all subjects)
1.9 (3.3)
n = 61
1.3 (2.5)
n = 61
0.6 (2.6)
95% CI −0.1 to 1.3
t(60) = 1.73, p = 0.09
Periods 1 and 2 c
(continued wear)
3.0 (3.2)
n = 25
1.1 (2.4)
n = 25
1.9 (2.7)
95% CI 0.7 to 3.0
t(24) = 3.45, p = 0.002
Periods 1 and 2 c
(discontinued wear)
(3.3)
n = 35
1.6 (2.7)
n = 35
−0.5 (2.1)
95% CI −1.2 to 0.3
t(34) = 1.29, p = 0.21
a

Analyzed as if for a parallel arm trial (independent samples t-test)

b

Mobility improvement scores all significantly different from 0.0 (one-sample t-tests, all p < 0.01)

c

Matched pairs analysis for the crossover (paired t-test)